Key Publications
MOST RECENT ORIGINAL ARTICLES
1. Mocciaro G, George A, Allison M, Frontini M, Huang-Doran I, Reiman F, Gribble F, Vidal-Puig A, Griffin JL, Azzu V*, Kay R*, Vacca M*. Oxidised apolipoprotein peptidome characterises metabolic dysfunction-associated steatotic liver disease (MASLD). Liver International 2025 Feb;45(2):e16200. doi: 10.1111/liv.16200.Liver Int 2025 Feb;45(2):e16200. doi: 10.1111/liv.16200 PMID: 39822152 * Last and corresponding authors.
2. Vacca M*$, Kamzolas I*, Harder LM*, Oakley F, Trautwein C, Hatting M, Ross T, Bernardo B, Oldenburger A, Hjuler ST, Ksiazek I, Lindén D, Schuppan D, Rodriguez-Cuenca S, Tonini MM, Castañeda TR, Kannt A, Rodrigues CMP, Cockell S, Govaere O, Daly AK, Allison M, Honnens de Lichtenberg K, Kim YO, Lindblom A, Oldham S, Andréasson AC, Schlerman F, Marioneaux J, Sanyal A, Afonso MB, Younes R, Amano Y, Friedman SL, Wang S, Bhattacharya D, Simon E, Paradis V, Burt A, Grypari IM, Davies S, Driessen A, Yashiro H, Pors S, Worm Andersen M, Feigh M, Yunis C, Bedossa P, Stewart M, Cater HL, Wells S, Schattenberg JM, Anstee QM; LITMUS Investigators; Tiniakos D$, Perfield JW$, Petsalaki E$, Davidsen P$, Vidal-Puig A$. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nat Metab. 2024 Jun 12. doi: 10.1038/s42255-024-01043-6 - PMID: 38867022 *Shared First Authors $Shared corresponding
3. Mocciaro G, Allison M, Jenkins B, Azzu V, Huang-Doran I, Herrera-Marcos LV, Hall Z, Murgia A, Susan D, Frontini M, Vidal-Puig A, Koulman A*, Griffin JL*, Vacca M*. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Mol Metab 2023 Jul;73:101728. doi: 10.1016/j.molmet.2023.101728 - PMID: 37084865 *Corresponding Authors
4. Mocciaro G, D'Amore S, Jenkins B, Kay R, Murgia A, Herrera-Marcos LV, Neun S, Sowton AP, Hall Z, Palma-Duran SA, Palasciano G, Reimann F, Murray A, Suppressa P, Sabbà C, Moschetta A, Koulman A, Griffin JL*, Vacca M*. Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome Int J Mol Sci 2022 Jun 17;23(12):6786. doi: 10.3390/ijms23126786 - PMID: 35743227 *Corresponding Authors
MOST RECENT REVIEW ARTICLES
1. Misceo D, Mocciaro G, D’Amore S*, Vacca M*. Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle Steatotic Liver Disease (SLD) and Hepatocellular carcinoma (HCC). Nutr Metab (Lond) 2024 Dec 23;21(1):112. doi: 10.1186/s12986-024-00871-3 PMID: 39716321 * Last and corresponding authors.
2. Leslie J, Geh D, Elsharkawy AM, Mann DA*, Vacca M*. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions J Hepatol 2022 Feb 12;S0168-8278(22)00076-9. doi: 10.1016/j.jhep.2022.01.029. PMID: 35157957 * Corresponding author